
Sign up to save your podcasts
Or


Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.
By Stone4.9
1010 ratings
Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.

14 Listeners

7,231 Listeners

722 Listeners

1,693 Listeners

8,651 Listeners

1,815 Listeners

6 Listeners

71 Listeners

21 Listeners

19,818 Listeners

1,349 Listeners

193 Listeners

15 Listeners

2 Listeners

3,132 Listeners